SYNTHETIC BIOLOGICS
Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The company is also developing monoclonal antibody therapies for the treatment of pertussis and novel discovery-stage biotherapeutics for the treatment of phenylketonuria.
SYNTHETIC BIOLOGICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2001-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.syntheticbiologics.com
Total Employee:
11+
Status:
Active
Contact:
(734) 332-7800
Email Addresses:
[email protected]
Total Funding:
32.88 M USD
Technology used in webpage:
Euro Font Awesome Common Name Invalid CPanel
Similar Organizations
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Inovio Pharmaceuticals
Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Society for Muscle Biology
Society for Muscle Biology is understanding and expanding the knowledge about muscle include development, function, genetics, and disease.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-14 | VCN Biosciences | VCN Biosciences acquired by Synthetic Biologics | N/A |
Investors List
MSD Partners
MSD Partners investment in Post-IPO Equity - Synthetic Biologics
Biotechnology and Biological Sciences Research Council
Biotechnology and Biological Sciences Research Council investment in Grant - Synthetic Biologics
Engineering and Physical Sciences Research Council
Engineering and Physical Sciences Research Council investment in Grant - Synthetic Biologics
Randal J. Kirk
Randal J. Kirk investment in Post-IPO Equity - Synthetic Biologics
Official Site Inspections
http://www.syntheticbiologics.com
- Host name: cpanel141.turbify.biz
- IP address: 138.91.107.244
- Location: Washington United States
- Latitude: 38.7095
- Longitude: -78.1539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 22747
More informations about "Synthetic Biologics"
Synthetic Biologics, Inc.
Synthetic Biologics, Inc. www.syntheticbiologics.com Updated 11.23.2021 December 2021See details»
Synthetic Biologics Rebrands as Theriva Biologics
Oct 12, 2022 Cookie Duration Description __cf_bm: 1 hour: This cookie, set by Cloudflare, is used to support Cloudflare Bot Management. _cfuvid: session: The _cfuvid cookie is used to allow the Cloudflare WAF to distinguish individual โฆSee details»
Synthetic Biologics - Org Chart, Teams, Culture & Jobs - The Org
View Synthetic Biologics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Synthetic Biologics - Overview, News & Similar companies
Sep 30, 2022 Synthetic Biologics to Participate in the BTIG Biotechnology Conference 2022 ROCKVILLE, Md., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Synthetic Biologics, Inc. (NYSE โฆSee details»
Synthetic Biologics, Inc - Cruelty Free Investing
Synthetic Biologics, Inc. is a clinical stage company, which develops therapeutics to protect the gut microbiome while targeting pathogen-specific diseases. Its products portfolio includes SYN โฆSee details»
Synthetic Biologics - Owler
Synthetic Biologicsโs Profile, Revenue and Employees. Synthetic Biologics is a Maryland-based clinical-stage company that develops and commercializes microbiome therapeutics for the โฆSee details»
Synthetic Biologics - VentureRadar
Website archive shows the site https://www.syntheticbiologics.com was first archived on 2012. Similar Companies: Assembly Biosciences, Inc. USA Publicly Traded Assembly Biosciences, โฆSee details»
Synthetic Biologics - Golden
A synthetic biology company developing therapeutics for the human microbiome. Overview Structured Data Issues Contributors Activity. ContentsSee details»
Synthetic Biologics, Inc. Company Information - Drugs.com
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for โฆSee details»
Synthetic Biologics (UGJCK56BHQU7) - highergov.com
Synthetic Biologics (UEI UGJCK56BHQU7, CAGE 7MG59) based in Rockville MD federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
Synthetic Biologics Announces Management Transitions in โฆ
Mar 23, 2022 -Frank Tufaro, Ph.D., appointed as Chief Operating Officer of Synthetic Biologics, transitioning from Chief Operating Officer of VCN Biosciences- -Manel Cascallฯ, Ph.D., โฆSee details»
Nextsource | Company Profile | Synthetic Biologics
Explore the company profile of Synthetic Biologics (syntheticbiologics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Synthetic Biologics Announces Formation of Scientific
May 5, 2022 Synthetic Biologics Announces Formation of Scientific Advisory Board to Advance Oncology PipelineSee details»
Synthetic Biologics Completes Acquisition of VCN Biosciences
Mar 11, 2022 โ Expands pipeline into oncology with unique, clinical-stage oncolytic viruses optimized for intravenous administration โ โ Strong cash position to support multiple inflection โฆSee details»
Synthetic Biologics Reports 2021 Year End Operational Highlights โฆ
Mar 16, 2022 For the year ended December 31, 2021 : 2020 : Operating Costs and Expenses: General and administrative $ 6,474 $ 5,029 : Research and developmentSee details»
Synthetic Biologics to Present at 2022 BIO CEO & Investor โฆ
ROCKVILLE, Md., Feb. 9, 2022 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in โฆSee details»
23 Synthetic Biology Companies You Should Know - Built In
Mar 26, 2024 Imagine a world in which all the planes in the sky are fueled by algae and the very breath you exhale can be turned into food. Everything, from plastic bags to clothing, is โฆSee details»
SynBio Canada
SynBio Canada aims to establish Canada as a leader in the field of synthetic biology, by bringing together academics, industry partners, and the general public to learn and collaborate.See details»
Synthetic Biologics - VentureRadar
Website archive shows the site https://www.syntheticbiologics.com was first archived on 2012. Similar Companies: RedHill Biopharma Israel Publicly Traded RedHill Biopharma is dedicated โฆSee details»
Synthetic Biology Manufacturers and Recent Developments
Synthetic Biology Key Players and their Developments. The synthetic biology market was estimated at US$ 16.39 billion in 2023 and is projected to grow to US$ 191.48 billion by 2034, โฆSee details»